XRCC4 and mucoepidermoid carcinoma: Interestingly, subgroup analysis showed that the association of RAD52-rs3748522 with SGC risk was the strongest in mucoepidermoid carcinoma, whereas the association of XRCC4-rs13180356 with SGC risk was the strongest in adenoid cystic carcinoma.